NCT02326155View on ClinicalTrials.gov

To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)

TerminatedOBSERVATIONAL

Enrollment

470

Participants

Timeline

Start Date

December 8, 2014

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions

Crohn's DiseaseUlcerative Colitis

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celltrion

INDUSTRY